The role of brain natriuretic peptide in prognostication and reclassification of risk in patients undergoing vascular surgery

Anaesthesia

Volumn 66, Issue 5, 2011, Pages 379-385

  Biccard, B M ^a,b   Naidoo, P ^c  

^a Inkosi Albert Luthuli Hospital   (South Africa)

^b Perioperative Research Unit   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN I;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REVISED CARDIAC RISK INDEX; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURGICAL PATIENT; SURGICAL RISK; VASCULAR SURGERY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; TROPONIN I; VASCULAR SURGICAL PROCEDURES; YOUNG ADULT;

EID: 79954459938     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2011.06694.x     Document Type: Article

References (21)

1. Hlatky MA, Greenland P, Arnett DK, et al., Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009; 119: 2408-16.
2. Rodseth RN,. B type natriuretic peptide-a diagnostic breakthrough in peri-operative cardiac risk assessment? Anaesthesia 2009; 64: 165-78.
3. Rodseth RN, Padayachee L, Biccard BM,. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 2008; 63: 1226-33.
4. Karthikeyan G, Moncur RA, Levine O, et al., Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies Journal of the American College of Cardiology 2009; 54: 1599-606.
5. Lee TH, Marcantonio ER, Mangione CM, et al., Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9. (Pubitemid 29416229)
6. Choi JH, Cho DK, Song YB, et al., Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in noncardiac surgery. Heart 2010; 96: 56-62.
7. Thygesen K, Alpert JS, White HD, et al., Universal definition of myocardial infarction. Circulation 2007; 116: 2634-53. (Pubitemid 350182388)
8. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR,. A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology 1996; 49: 1373-9. (Pubitemid 27028925)
9. Fleisher LA, Beckman JA, Brown KA, et al., ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007; 116: 1971-96.
10. Poldermans D, Bax JJ, Boersma E, et al., Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. European Heart Journal 2009; 30: 2769-812.
11. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS,. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in Medicine 2008; 27: 157-72. (Pubitemid 351193639)
12. Cuthbertson BH, Amiri AR, Croal BL, et al., Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. British Journal of Anaesthesia 2007; 99: 170-6. (Pubitemid 47249387)
13. Ford MK, Beattie WS, Wijeysundera DN,. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Annals of Internal Medicine 2010; 152: 26-35.
14. Cook NR, Ridker PM,. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Annals of Internal Medicine 2009; 150: 795-802.
15. Khan SQ, Narayan H, Ng KH, et al., N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome. Clinical Science (London) 2009; 117: 31-9.
16. Melander O, Newton-Cheh C, Almgren P, et al., Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. Journal of the American Medical Association 2009; 302: 49-57.
17. Ridley S,. Cardiac scoring systems-what is their value? Anaesthesia 2003; 58: 985-91. (Pubitemid 37254178)
18. Law MR, Wald NJ,. Risk factor thresholds: their existence under scrutiny. British Medical Journal 2002; 324: 1570-6. (Pubitemid 34713139)
19. Gibson SC, Marsh A, Berry C, et al., Should pre-operative troponin be a standard requirement in patients undergoing major lower extremity amputation? European Journal of Vascular and Endovascular Surgery 2006; 31: 637-41. (Pubitemid 43792944)
20. Sarveswaran J, Ikponmwosa A, Asthana S, Spark JI,. Should cardiac troponins be used as a risk stratification tool for patients with chronic critical limb ischaemia? European Journal of Vascular and Endovascular Surgery 2007; 33: 703-7. (Pubitemid 46672806)
21. Bolliger D, Seeberger MD, Lurati Buse GA, et al., A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery. Anesthesia and Analgesia 2009; 108: 1069-75.